Suchergebnisse
Howmet Gains From Strength in Defense Aerospace: Can the Momentum Last?
Howmet Aerospace Inc. HWM is benefiting from persistent strength in its defense aerospace market. After experiencing growth of 19%, 21% and 24% in the first, second and third quarters, respectively
Adobe's Creative and Marketing Growth Surges: More Upside Ahead?
Adobe ADBE is benefiting from the growth of its Creative and Marketing Professionals segment, driven by AI adoption, core subscription strength and enterprise platform expansion. Creative and
3 Aerospace-Defense Stocks to Buy on Strong Defense & Air Travel Boom
Diverse Offerings Aid Gartner Amid Stiff Rivalry & High Talent Cost
Gartner Inc. IT is benefiting from its diverse offerings across domains, reducing reliance on single revenue streams and ensuring a stable top line. Its rich domain expertise and technology-related
3 Best Breakout Stocks to Buy Now for Big Upside in 2026
Investors can benefit from a more active approach to stock selection by tracking potential breakout opportunities within defined price ranges. In this strategy, a stock should be sold if it falls
Is Chewy Stock a Buy, Hold or Sell at Its Current Valuation?
Chewy, Inc. CHWY has emerged as a dominant player in the online pet retail space, benefiting from the steady growth in pet ownership and the ongoing shift toward e-commerce. However, despite the
Key Reasons to Add Healthpeak Properties Stock to Your Portfolio Now
Healthpeak Properties, Inc. DOC is well-positioned to benefit from robust demand for lab assets and an expected rise in senior citizens’ healthcare spending. Accretive investments and a solid
Waste Management Market Aids Republic Services Amid Low Liquidity
Republic Services, Inc. RSG is benefiting from an expanding North American solid waste management market. The rising popularity of electric vehicles further reduces its fleet emissions and positions
Organic Revenue Growth & Strategic Acquisitions Fuel Corpay's Growth
Corpay, Inc. CPAY is benefiting from continuous organic top-line growth, driven by higher volumes and increased revenue per transaction from certain payment programs. Acquisitions and strategic
Here's Why You Should Retain BDX Stock in Your Portfolio Now
Becton, Dickinson and Company BDX is benefiting from its focused transformation into a pure-play MedTech company, supported by strong execution of its BD 2025 strategy. The company’s continued
Will Health Benefits Weakness Drag Elevance's Q1 Earnings?
Elevance Health, Inc. ELV is set to report its first-quarter 2026 results on April 22, 2026, before the opening bell. The Zacks Consensus Estimate for the to-be-reported quarter’s earnings is
Why Anthropic's Custom Chip Plans Could Benefit Broadcom
Large language model developer Anthropic is one of the top names in the artificial intelligence (AI) race and is growing incredibly fast. From the end of 2025 to early April, Anthropic says its
Can Seagate's Strong Cash Flow Outweigh its Leverage Concerns?
Seagate Technology Holdings plc STX has been a prominent player in the global data storage market, benefiting from secular tailwinds such as cloud computing, AI workloads and data center expansion
Can Quanta Gain From Rising Utility and Power Infrastructure Spend?
Quanta Services, Inc. PWR is positioned to benefit from sustained growth in utility and power infrastructure spending, driven by rising electricity demand, grid modernization needs and the
3 Foreign Auto Stocks Poised to Benefit From Strength in Key Markets
Alphabet Shares Rise 7% YTD: Buy, Sell, or Hold the GOOGL Stock?
Alphabet GOOGL shares have returned 7.4% year to date (YTD), outperforming the Zacks Computer & Technology sector’s 4.1%. The company’s prospects are expected to benefit from its growing AI-powered
Eversource Gains From Grid Modernization & Infrastructure Development
Eversource Energy ES benefits from grid modernization and stable demand from residential, commercial and industrial customers. Its strategic investment in infrastructure development enables it to
LLY's Oral GLP-1 Pill Foundayo Shows Heart Benefits in Diabetes Study
Eli Lilly and Company LLY announced that a phase III study, ACHIEVE-4, evaluating its newly approved oral GLP-1 weight-loss pill Foundayo (orforglipron), for treating patients with type II diabetes


